MTOR and cancer: The phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway is the most frequently and aberrantly activated pathway in many types of cancers and plays a key role in cancer cell growth, survival, angiogenesis, and metastasis [14,15].